Ted W. Love, Director at Cascadian Therapeutics, Inc. (CASC), bought 23,000 shares at $4.24 ($98K) on 2017-02-02, disclosed to the SEC on 2017-02-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GBT | SELL | 2020-01-23 | $13.1M | — | Filing → |
| GBT | SELL | 2019-12-09 | $11.3M | — | Filing → |
| GBT | BUY | 2016-01-07 | $150K | — | Filing → |